ng28ÄϹ¬ºÍÉú»¯Ñ§¾Í¹ÇÊàŦÑ×ÖÎÁƼÁSI-613ÔÚº«¹úµÄÁªºÏÉÏÊÐÇ©¶©Ð­Òé

ng28ÄϹ¬Öêʽ»áÉ磨×ܲ¿£º¶«¾© £¬CEO£ºÄÚÌÙÇç·ò £¬Ï³ơ°ng28ÄϹ¬¡±£©ºÍÉú»¯Ñ§¹¤ÒµÖêʽ»áÉ磨×ܲ¿£º¶«¾© £¬×ܲãºË®¹È½¨ £¬¡°Éú»¯Ñ§¡±£©½üÈÕÐû²¼ £¬Á½¼Ò¹«Ë¾ÒѾÍÉú»¯Ñ§Ê×´´µÄ¹ÇÊàŦÑ×ÖÎÁƼÁSI-613£¨Ë«ÂÈ·ÒËá½áºÏ͸Ã÷ÖÊËáÄÆ£©ÔÚº«¹úµÄÁªºÏÉÏÊÐÇ©¶©Ð­Òé¡£ÕâÊÇ×Ông28ÄϹ¬ºÍÉú»¯Ñ§ÓÚ2020Äê4ÔÂ1ÈÕ¾ÍSI-613ÔÚÖйúµÄÅäºÏ¿ª·¢ºÍÁªºÏÉÏÊÐÇ©ÊðЭÒéÒÔÀ´ £¬µÞ½áÁªºÏÉÏÊÐЭÒéµÄµÚ¶þ¸ö¹ú¼Ò¡£

ƾ¾Ý¸ÃЭÒé £¬Eisai Korea Inc.£¨ng28ÄϹ¬×Ó¹«Ë¾£©½«»ñµÃSI-613ÔÚº«¹úµÄ¶À¼ÒÉÏÊÐȨ £¬²¢ÉêÇëÆäÖÆÔìºÍÉÏÊÐÐí¿É¡£»ñÅúºó £¬Éú»¯Ñ§½«Ïòng28ÄϹ¬¹©Ó¦²úÆ· £¬¶øng28ÄϹ¬½«ÂôÁ¦·ÖÏú¡£ng28ÄϹ¬½«ÏòÉú»¯Ñ§Ö§¸¶Ô¤¸¶¿î £¬²¢µÖ´ïÏúÊÛÀï³Ì±®¡£

¹ÇÊàŦÑ×ÊÇÒ»ÖÖÓÉÀÏ»¯ºÍÆäËûÒòËØµ¼ÖµÄÊàŦÈí¹ÇËðÉËÒýÆðµÄ¼²²¡ £¬Òý·¢Ñ×Ö¢ºÍÌÛÍ´ £¬´Ó¶øµ¼ÖÂÉú»îÖÊÁ¿£¨QOL£©Ï½µ¡£Ï¥¹ÇÊàŦÑ×ÊÇÆä¼²²¡ÖÐ×î³£¼ûµÄ²¡ÀýÖ®Ò» £¬º«¹úÏ¥¹ÇÊàŦÑ×»¼ÕßµÄÈËÊýÔ¤¼ÆÔ¼Îª320Íò¡£*1Ô¤¼ÆËæ×ÅÈË¿ÚÀÏÁ仯 £¬¸ÃÊý×Ö½«¼ÌÐøÔö¼Ó¡£

SI-613ÊÇÓÉÉú»¯Ñ§ÀûÓÃÆäרÓÐÒ©Îï½áºÏ¼¼Êõ½«Í¸Ã÷ÖÊËáºÍË«ÂÈ·ÒËᣨһÖÖ¿¹Ñ×Ò©Î»¯Ñ§½áºÏ¶ø³ÉµÄË«ÂÈ·ÒËá½áºÏ͸Ã÷ÖÊËáÄÆ¡£ÕâÖÖÎïÖʾßÓÐË«ÂÈ·ÒËáµÄֹʹºÍ¿¹Ñ××÷Óà £¬³ý͸Ã÷ÖÊËáÄÆµÄÊàŦ¹¦Ð§¸ÄÉÆ×÷ÓÃÍâ £¬»¹Ö¼ÔÚͨ¹ýÊÍҩϵͳ*3Æðµ½»ºÊÍ×÷ÓÃ*2¡£Òò´Ë £¬Ô¤¼ÆSI-613¿É¿ìËÙÇÒÁ¬Ðø¼õÇáÓë¹ÇÊàŦÑ×Ïà¹ØµÄÌÛÍ´ºÍÑ×Ö¢¡£

ƾ¾Ý¸ÃЭÒé £¬ng28ÄϹ¬Ö¼ÔÚͨ¹ýÀûÓÃÆäº«¹úÒµÎñ»ñµÃµÄ֪ʶºÍÍøÂç £¬Âú×ãÏ¥¹ÇÊàŦÑ×»¼Õßδ»ñµÃÂú×ãµÄÒ½ÁÆÐèÇó¡£Éú»¯Ñ§½«Í¨¹ýÀûÓÃng28ÄϹ¬µÄº«¹úÒµÎñ»ùµØ £¬Ñ°ÇóÔÚº«¹úʵÏÖSI-613¼ÛÖµµÄ×î´ó»¯¡£

Á½¼Ò¹«Ë¾½«Í¨¹ýSI-613µÄÉÌÒµ»¯ £¬ÔÚº«¹úÌṩÖÎÁÆÏ¥¹ÇÊàŦÑ×µÄÐÂÖÎÁƼƻ® £¬ÒÔÔö½ø¸ÄÉÆ»¼ÕßµÄQOL¡£

<±à¼­×¢ÊÍ>

1. ¹ØÓÚSI-613

SI-613ÊÇÓÉÉú»¯Ñ§ÀûÓÃÆä¶ÀÍ̵ÄÒ©Îï½áºÏ¼¼Êõ £¬½«Í¸Ã÷ÖÊËáºÍË«ÂÈ·ÒËᣨһÖÖ¿¹Ñ×Ò©Î»¯Ñ§½áºÏ¶ø³ÉµÄË«ÂÈ·ÒËá½áºÏ͸Ã÷ÖÊËáÄÆ¡£ÕâÖÖÎïÖʾßÓÐË«ÂÈ·ÒËáµÄֹʹºÍ¿¹Ñ××÷Óà £¬³ý͸Ã÷ÖÊËáÄÆµÄÊàŦ¹¦Ð§¸ÄÉÆ×÷ÓÃÍâ £¬»¹Ö¼ÔÚͨ¹ýÊÍҩϵͳ*3Æðµ½»ºÊÍ×÷ÓÃ*2¡£Ô¤¼ÆSI-613¿É¿ìËÙÇÒÁ¬Ðø¼õÇáÓë¹ÇÊàŦÑ×£¨ÈçÏ¥ÊàŦ£©Ïà¹ØµÄÌÛÍ´ºÍÑ×Ö¢¡£ÁíÍâ £¬ÓÉÓÚͨ¹ý×¢É佫ÆäÖ±½Ó¸øÒ©ÖÁÊàŦǻÖÐ £¬ÈÏΪ˫ÂÈ·ÒËáÈ«Éí̻¶Á¿ºÍÒýÆðÈ«ÉíÒ©Îï²»Á¼·´Ó¦µÄΣº¦µÍ¡£

2020Äê1ÔÂ6ÈÕ £¬Éú»¯Ñ§Ìá½»Ò»·ÝÐÂÒ©ÉêÇ루ϳơ°NDA¡±£© £¬ÉêÇëÅú×¼ÔÚÈÕ±¾ÖÆÔìºÍÉÏÊÐSI-613ÒÔÖÎÁƹÇÊàŦÑ×£¨Ï¥ÊàŦ¡¢÷ÅÊàŦºÍõ×ÊàŦ£©¡£ng28ÄϹ¬ºÍÉú»¯Ñ§ÓÚ2020Äê4ÔÂ1ÈÕ¾ÍSI-613ÔÚÖйúµÄÅäºÏ¿ª·¢ºÍÉÏÊÐÁªÃËÇ©ÊðЭÒé¡£

 

2. ¹ØÓÚng28ÄϹ¬Öêʽ»áÉç

ng28ÄϹ¬Öêʽ»áÉ罫ÆóҵʹÃü½ç˵Ϊ¡°ÎÒÃǽ«»¼Õß¼°¼ÒÊôµÄÀûÒæ·ÅÔÚÊ×λ £¬ÎªÌáÉýÆä¸£ìí×ö³öТ¾´¡± £¬¼´ÎªÌåÌùÈËÀཡ¿µ£¨hhc£©ÀíÄî¡£±é²¼È«ÇòµÄÑз¢»ú¹¹¡¢Éú²ú»ùµØºÍÓªÏúÁ¥Êô¹«Ë¾×ܹ²ÓµÓнü10,000ÃûÔ±¹¤¡£ÎÒÃÇŬÁ¦Êµ¼ùhhcÀíÄî £¬Í¨¹ýÌṩÁ¢Òì²úÆ·Âú×ã´ýÂú×ãµÄÒ½ÁÆÐèÇó £¬ÌرðÊÇÔÚÖ×ÁöѧºÍÉñ¾­Ñ§ÁìÓò¡£×÷Ϊһ¼ÒÈ«ÇòÖÆÒ©¹«Ë¾ £¬ÎÒÃǵÄʹÃüÊÇͨ¹ýÓëÖ÷ÒªÀûÒæÏà¹Ø·½ÏàÖú £¬¸ÄÉÆÉú³¤Öйú¼ÒºÍÐÂÐ˹ú¼ÒµÄÒ©Æ·»ñÈ¡ÇþµÀ £¬´Ó¶øÊ¹ÊÀ½ç¸÷µØµÄ»¼ÕßÊÜÒæ¡£

ÓûÁ˽â¸ü¶àÓйØng28ÄϹ¬Öêʽ»áÉçµÄÐÅÏ¢ £¬Çë»á¼ûhttps://www.eisai.com

 

3. ¹ØÓÚÉú»¯Ñ§¹¤ÒµÖêʽ»áÉç

Éú»¯Ñ§¹¤ÒµÖêʽ»áÉçÊÇÒ»¼ÒÑз¢ÐÍÖÆÒ©¹«Ë¾ £¬×¨×¢ÓÚÌÇ¿ÆÑ§×÷ΪרҵÁìÓò¡£×Ô1947Ä꽨Á¢ÒÔÀ´ £¬Éú»¯Ñ§Ò»Ö±×¨×¢ÓÚÌÇ¿ÆÑ§µÄ¿ÉÄÜÐÔ £¬²¢ÔڹǿƼ²»¼ºÍÑۿƼ²²¡ÁìÓò¿ª·¢Ô­´´ÇÒÓÐÒæµÄÒ©Îï²úÆ·ºÍÒ½ÁÆÆ÷е¡£ÔÚÆæÌØÒµÎñģʽ£¨¼´×¨×¢ÓÚÑз¢ºÍÖÆÔì £¬¶øÎÞÄÚ²¿Ò©Æ·ÏúÊÛ²¿·Ö£©Ï £¬Éú»¯Ñ§Í¨¹ýÓëÔÚÌØ¶¨¹ú¼ÒºÍ²úÆ·ÁìÓò¾ßÓÐÓÅÊÆµÄ¹«Ë¾ÏàÖú £¬ÔÚÈ«Çò¹æÄ£ÄÚ½«²úÆ·ÉÏÊÐ £¬ÎªÈ«ÊÀ½çÈËÃñµÄ½¡¿µºÍ³ä·ÖµÄÉú»î×ö³öТ¾´¡£

ÓûÁ˽â¸ü¶àÓйØÉú»¯Ñ§¹¤ÒµÖêʽ»áÉçµÄÐÅÏ¢ £¬Çë»á¼ûhttps://www.seikagaku.co.jp/en/

²Î¿¼Îļþ£º

*1: For the estimated data regarding the number of patients with knee osteoarthritis

¡¤??Vital Data – Korea Statistical Information Service, URL:http://kosis.kr/index/index.do

¡¤? Changes in the number of patients – Healthcare Bigdata Hub, URL:https://opendata.hira.or.kr/home.do

*2: Sustained release is a gradual release of the active pharmaceutical ingredients of a drug to achieve a sustained therapeutic effect.

*3: Drug delivery system (DDS) is a technology for the controlled release, targeting, and absorption improvement of drugs.